Viewing Study NCT05086094

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-02-24 @ 9:44 AM
Study NCT ID: NCT05086094
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2022-10-06
First Post: 2021-10-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)
Sponsor: Biohaven Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple System Atrophy (MSA) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple System Atrophy View
None MSA View
None verdiperstat View
None BHV3241 View
None MPO inhibitor View
None Myeloperoxidase inhibitor View
None MSA-P View
None MSA-C View